November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering Han-Oh ParkFounder & CEO at siRNAgen TherapeuticsSpeaker
Profile
| 1984 B.S., Chemistry at Seoul National University 1986 M.S., Chemistry at Korea Advanced Institute of Science and Technology (KAIST) 1992 Ph.D., Chemistry at Korea Advanced Institute of Science and Technology (KAIST) 1992-Present Founder, CEO & Chairman, BIONEER, Daejeon, Korea 2019-Present Founder & CEO, siRNAgen Therapeutics (Subsidiary of BIONEER), Daejeon, Korea 2001-Present Vice-President, Korea Biotechnology Industry Organization 2013-2014 Committee Member, Presidential Advisory Council on Science & Technology 2021-Present Member, The National Academy of Engineering of Korea 2022-Present Co-chair, Korean Society for Synthetic Biology 2023-Present President, Korea R&D Industry Association 2020 Citation for the Contribution of Health and Medical Technology Promotion, Minister of Health and Welfare, Korea 2021 Gold Tower Order of Industrial Service Merit, Government of Korea 2023 POSCO TJ Park Prize - 2023 Technology Prize Winner, POSCO TJ Park Foundation, Korea 2025 FACS Award for Distinguished Contribution to Economic Advancement, Federation of Asian Chemical Societies |
Agenda Sessions
Immunology: siRNAgen Therapeutics: Midsize Pharma
, 17:00View Session